Internet of Things - IOT

This Frost & Sullivan research service focuses on US Department of Defense (DoD) computer software program spending and contracts. The DoD makes extensive use of computer software for both enterprise business functions and specialized combat mission systems. It has approved a software modernization strategy that is ensuring stable budgets, improve...

This deliverable provides insights on the many macro issues facing the pharma and biotech industry. The industry is currently in a state of transition and is faced with a myraid of challenges including the dreaded patent cliff. This research service presents a total market forecast, market share analysis by leading companies, top therapeutic class...

This research analyses the current and future economic trends and its impact on the pumps market in global biotech industry. The applications have been analysed across the globe and also a growth trend based on the three broad product classifications has been provided. The mega drivers with their corresponding implementation time have been discusse...

This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...

Open Source Innovation in the context of pharma and biotech is an issue based deliverable that gives an overview of this space and analyses the key drivers and barriers of this area. It gives an overview of the key problems faced by the pharmaceutical industry today, past, present and future strategies to tackle these problems, new strategies to im...

This briefing from the beginning of 2010 is on macro level dynamics in the global pharmaceutical and biotechnology industry. It is being made available for the value of our subscribers.

This market insight on contract sales and marketing organisations throws light on the changing dynamics and the opportunities that lie ahead for these organisations in the future.

This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical research services generated by Frost & Sullivan, customer research findings based on approximately 1,000 end-user interviews approximately 50,000 hours of...

This issue of Vital Signs, released on May 18, 2009, provides a strategic overview of opportunities and issues in the pharmaceutical and biotechnology outsourcing services markets. Additionally, a company spotlight is provided for Aerie Pharmaceuticals, an emerging pharma company focused on glaucoma. Reimbursement and regulatory news from the FDA i...